Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erenumab for Chronic Migraine With Medication Overuse Headache (Phase 4, Czechia)
2018-003342-16Phase 4Completed
- Sponsor
- Amgen
- Start
- Jun 2019
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic migraine, medication overuse headache (MOH) and migraine comparing Erenumab with Placebo (2 arms). Primary endpoint: Absence of medication overuse headache at month 6. Started Jun 2019; status: completed.
02
Drugs
erenumab
03
Conditions
chronic migrainemedication overuse headache (MOH)migraine
Beyond the preview
Go deeper on 2018-003342-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003342-16.